This guideline includes statements and recommendations based on available evidence about the management of early breast cancer in women with an identified BRCA1 or BRCA2 gene mutation or at high risk of such a gene mutation predisposing to breast cancer. The guideline provides health professionals with information designed to assist in making management recommendations for improved patient outcomes.
Incorporates published evidence to 2013
© Cancer Australia 2014
- File size:
- 324.24 KB
- ISBN:
- 978-1-74127-268-0
- Document status:
- Greater than 5 years. This resource was developed, reviewed or revised more than 5 years ago and may no longer reflect current evidence or best practice.
- Cancer type:
- Breast cancer
- Publication audience:
- Clinical practice guidelines
- Year of publication:
- 2014
